Literature DB >> 2912971

Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and charge.

T C Wright1, J J Castellot, M Petitou, J C Lormeau, J Choay, M J Karnovsky.   

Abstract

The glycosaminoglycan heparin inhibits the growth of several cell types in vitro including smooth muscle cells and rat cervical epithelial cells. The commercially available heparin which has antiproliferative activity is a structurally heterogeneous polymer that undergoes extensive modifications during maturation. In this report we have performed structure-function studies on heparin's antiproliferative activity using three different cell types: both rat and calf vascular aortic smooth muscle cells and rat cervical epithelial cells. The minimal oligosaccharide size requirements for antiproliferative activity were determined for the three cell types by using oligosaccharide fragments of defined length prepared by nitrous acid cleavage and gel filtration and a synthetic pentasaccharide. The size requirements are similar but not identical for the different cell types. Hexasaccharide fragments are antiproliferative for all three cell types but the synthetic pentasaccharide inhibits the growth of only the rat and calf vascular aortic smooth muscle cells. The interdependence between size and charge for antiproliferative activity was investigated using chemically modified oligosaccharides as well as oligosaccharides prepared from heparin and separated into fractions of differing charge by ion-exchange chromatography. There is a strong interdependence between size and charge for antiproliferative activity. For example, increasing the charge of inactive tetrasaccharide fragments by O-oversulfation makes them antiproliferative whereas reducing the charge of active larger fragments causes them to loose their antiproliferative activity. Finally the importance of 2-O-sulfate glucuronic acid moieties for antiproliferative activity was investigated using heparin preparations that lack 2-O-sulfate glucuronic acid. These compounds possess antiproliferative activity indicating that 2-O-sulfate glucuronic acid is not required for antiproliferative activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912971

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.

Authors:  Jeffrey A Beamish; Ping He; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

2.  The heparin-binding lectin from ovine placenta: purification and identification as histone H4.

Authors:  A L Ambrosio; M M Iglesias; C Wolfenstein-Todel
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

3.  Inhibition of autonomous human keratinocyte proliferation and amphiregulin mitogenic activity by sulfated polysaccharides.

Authors:  P W Cook; P A Mattox; W W Keeble; G D Shipley
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

4.  Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship.

Authors:  A Syrokou; G Tzanakakis; T Tsegenidis; A Hjerpe; N K Karamanos
Journal:  Cell Prolif       Date:  1999 Apr-Jun       Impact factor: 6.831

5.  A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin.

Authors:  P W Cook; P A Mattox; W W Keeble; M R Pittelkow; G D Plowman; M Shoyab; J P Adelman; G D Shipley
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

6.  Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells.

Authors:  A D Snow; R P Bolender; T N Wight; A W Clowes
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

7.  Inhibition of serum-induced proliferation of bovine tracheal smooth muscle cells in culture by heparin and related glycosaminoglycans.

Authors:  S A Kilfeather; S Tagoe; A C Perez; K Okona-Mensa; R Matin; C P Page
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Heparin and structurally related polymers attenuate eotaxin-1 (CCL11) release from human airway smooth muscle.

Authors:  V Kanabar; C P Page; D E Simcock; C Karner; K Mahn; B J O'Connor; S J Hirst
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

9.  Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo.

Authors:  L A Pukac; G M Hirsch; J C Lormeau; M Petitou; J Choay; M J Karnovsky
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

10.  Cell surface heparan sulfate proteoglycan and chondroitin sulfate proteoglycan of arterial smooth muscle cells.

Authors:  I J Edwards; W D Wagner
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.